Silo Pharma buys software assets from Parkview Consulting in stock deal
The company issued 165,000 shares to acquire technology and IP from a firm led by its crypto advisory board's lead strategic advisor.
SEC filing
Latest
2 stories
Wednesday, August 19
Tuesday, July 14
Silo Pharma closes $4 million private placement priced at-the-market
The Sarasota biopharma entered agreements July 9 and closed the deal July 10, selling shares, pre-funded warrants, and two series of common warrants.
SEC filing (2)